Once at the tumor site, activated CD8+ T cells recognize the tumor-specific antigen present at the surface of the cancer cell through the interaction between the antigenic peptide-MHC class I complex and the T cell receptor (TCR) (2). The gene discussed is CD8A; the disease is neoplasm.